| 2020 |
BEHRT: Transformer for Electronic Health Records
10.1038/s41598-020-62922-y
Authors: Y. Li, S. Rao, J. Solares, A. Hassaine, R. Ramakrishnan, D. Canoy, Y. Zhu, K. Rahimi, G. Salimi-Khorshidi |
| 2006 |
Bell\textquoterights palsy and parenteral inactivated influenza vaccine
Authors: J. Stowe, N. Andrews, L. Wise, E. Miller |
| 2023 |
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
10.1186/s12931-023-02523-1
Authors: A. Ismaila, K. Rothnie, R. Wood, V. Banks, L. Camidge, A. Czira, C. Compton, R. Sharma, S. Millard, O. Massey, D. Halpin |
| 2018 |
Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension
10.1001/jamainternmed.2018.4684
Authors: J. Sheppard, S. Stevens, R. Stevens, U. Martin, J. Mant, F. Hobbs, R. McManus |
| 2018 |
Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy
10.1177/0962280218804275
Authors: D. Wolfson, A. Best, V. Addona, J. Wolfson, S. Gadalla |
| 2019 |
Benign tumors in myotonic dystrophy type I target disease-related cancer sites
10.1002/acn3.50856
Authors: R. Alsaggaf, D. St George, M. Zhan, R. Pfeiffer, Y. Wang, L. Anderson, Z. Liu, J. Koshiol, A. Bauer, K. Wagner, M. Greene, S. Amr, S. Gadalla |
| 2015 |
Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis
10.1007/s40264-015-0319-3
Authors: P. Imfeld, M. Bodmer, S. Jick, C. Meier |
| 2015 |
Benzodiazepines and risk of death: Results from two large cohort studies in France and UK
10.1016/j.euroneuro.2015.07.006
Authors: A. Palmaro, J. Dupouy, M. Lapeyre-Mestre |
| 2020 |
Beta 2 agonists and the incidence of Parkinson\textquoterights disease
10.1093/aje/kwaa012
Authors: F. Giorgianni, P. Ernst, S. Dell'Aniello, S. Suissa, C. Renoux |
| 2014 |
Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study
10.1111/bjd.12894
Authors: C. McCourt, H. Coleman, L. Murray, M. Cantwell, O. Dolan, D. Powe, C. Cardwell |
| 2013 |
Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort
10.1093/ije/dyt196
Authors: C. Cardwell, H. Coleman, L. Murray, F. Entschladen, D. Powe |
| 2013 |
beta-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort
10.1093/annonc/mdt381
Authors: B. Hicks, L. Murray, D. Powe, C. Hughes, C. Cardwell |
| 2017 |
Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism
10.1002/pds.4197
Authors: C. Renoux, S. Dell'Aniello, B. Brenner, S. Suissa |
| 2021 |
Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study
10.1371/journal.pmed.1003615
Authors: V. Varma, Y. Wang, Y. An, S. Varma, M. Bilgel, J. Doshi, C. Legido-Quigley, J. Delgado, A. Oommen, J. Roberts, D. Wong, C. Davatzikos, S. Resnick, J. Troncoso, O. Pletnikova, R. O\textquoterightBrien, E. Hak, B. Baak, R. Pfeiffer, P. Baloni, S. Mohmoudiandehkordi, K. Nho, R. Kaddurah-Daouk, D. Bennett, S. Gadalla, M. Thambisetty |
| 2022 |
Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data
10.1371/journal.pone.0269970
Authors: Y. Aoki, C. Cabrera, M. Ouwens, K. Bamberg, J. Nyström, I. Raz, B. Scirica, B. Hamrén, P. Greasley, D. Rekić |
| 2017 |
Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study
10.1136/bmjopen-2017-018153
Authors: S. Sinnott, K. Mansfield, M. Schmidt, K. Bhaskaran, L. Smeeth, D. Nitsch, L. Tomlinson |
| 2016 |
Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study
10.1002/pds.4042
Authors: J. Spoendlin, C. Meier, S. Jick, C. Meier |
| 2011 |
Bisphosphonates and esophageal cancer\textendasha pathway through the confusion
10.1038/nrrheum.2011.60
Authors: W. Dixon, D. Solomon |
| 2012 |
Bisphosphonates and risk of upper gastrointestinal cancer\textendasha case control study using the General Practice Research Database (GPRD)
10.1371/journal.pone.0047616
Authors: E. Wright, P. Schofield, P. Seed, M. Molokhia |
| 2016 |
Bisphosphonates as potential adjuvants for patients with cancers of the digestive system
10.3748/wjg.v22.i3.906
Authors: C. Ang, E. Doyle, A. Branch |
| 2021 |
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
10.3310/hta25170
Authors: D. Robinson, M. Ali, V . Y. Strauss, L. Elhussein, B. Abrahamsen, N. Arden, Y. Ben-Shlomo, F. Caskey, C. Cooper, D. Dedman, A. Delmestri, A. Judge, M. Javaid, D. Prieto-Alhambra |
| 2013 |
Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK
10.1016/j.vaccine.2013.08.024
Authors: K. Donegan, R. Beau-Lejdstrom, B. King, S. Seabroke, A. Thomson, P. Bryan |
| 2019 |
Bleeding After Hospital Discharge Following Acute Coronary Syndrome: Incidence, Types, Timing, and Predictors
10.1161/jaha.119.013679
Authors: N. Ismail, K. Jordan, U. Kadam, J. Edwards, T. Kinnaird, M. Mamas |
| 2023 |
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies
10.3310/mnjy9014
Authors: J. Harris, K. Pouwels, T. Johnson, J. Sterne, C. Pithara, K. Mahadevan, B. Reeves, U. Benedetto, Y. Loke, D. Lasserson, B. Doble, N. Hopewell-Kelly, S. Redwood, S. Wordsworth, A. Mumford, C. Rogers, M. Pufulete |
| 2021 |
Blood cholesterol and risk of dementia in more than 1.8 million people over two decades: a retrospective cohort study
10.1016/S2666-7568(21)00150-1
Authors: M. Iwagami, N. Qizilbash, J. Gregson, I. Douglas, M. Johnson, N. Pearce, S. Evans, S. Pocock |
| 2020 |
Blood eosinophil count predicts treatment failure and hospital readmission for COPD
10.1183/23120541.00188-2020
Authors: M. Kerkhof, I. Chaudhry, I. Pavord, M. Miravitlles, Kook Rhee, D. Halpin, O. Usmani, R. Jones, J. Kocks, M. Alacqua, T. Morris, A. Kaplan, D. Price |
| 2019 |
Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD)
10.1080/15412555.2019.1608172
Authors: O. Oshagbemi, F. Franssen, S. van Kraaij, D. Braeken, E. Wouters, A. van der Zee, J. Driessen, F. de Vries |
| 2018 |
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
10.1002/pds.4655
Authors: O. Oshagbemi, F. Franssen, D. Braeken, Y. Henskens, E. Wouters, A. van der Zee, A. Burden, F. de Vries |
| 2022 |
Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
10.1183/23120541.00606-2021
Authors: H. Ashdown, M. Smith, E. McFadden, I. Pavord, C. Butler, M. Bafadhel |
| 2019 |
Blood pressure and risk of dementia and its subtypes: a historical cohort study with long-term follow-up in 2.6~million people
10.1111/ene.14030
Authors: J. Gregson, N. Qizilbash, M. Iwagami, I. Douglas, M. Johnson, N. Pearce, S. Pocock |
| 2016 |
Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke
10.1161/strokeaha.116.012658
Authors: C. Emdin, P. Rothwell, G. Salimi-Khorshidi, A. Kiran, N. Conrad, T. Callender, Z. Mehta, S. Pendlebury, S. Anderson, H. Mohseni, M. Woodward, K. Rahimi |
| 2022 |
Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies
10.1093/cvr/cvac135
Authors: M. Nazarzadeh, Z. Bidel, H. Mohseni, D. Canoy, A. Pinho-Gomes, A. Hassaine, A. Dehghan, D. Tregouet, N. Smith, K. Rahimi |
| 2020 |
Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality
10.1093/ageing/afaa028
Authors: J. Masoli, J. Delgado, L. Pilling, D. Strain, D. Melzer |
| 2018 |
Blood Pressure Trajectories in the 20 Years Before Death
10.1001/jamainternmed.2017.7023
Authors: J. Delgado, K. Bowman, A. Ble, J. Masoli, Y. Han, W. Henley, S. Welsh, G. Kuchel, L. Ferrucci, D. Melzer |
| 2023 |
BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record data
10.1186/s41512-022-00138-6
Authors: P. Virdee, C. Bankhead, C. Koshiaris, C. Drakesmith, J. Oke, D. Withrow, S. Swain, K. Collins, L. Chammas, A. Tamm, T. Zhu, E. Morris, T. Holt, J. Birks, R. Perera, F. Hobbs, B. Nicholson |
| 2015 |
BMI and risk of dementia in two million people over two decades: a retrospective cohort study
10.1016/s2213-8587(15)00033-9
Authors: N. Qizilbash, J. Gregson, M. Johnson, N. Pearce, I. Douglas, K. Wing, S. Evans, S. Pocock |
| 2021 |
Body mass index and cancer mortality in patients with incident type 2 diabetes: A population-based study of adults in England
10.1111/dom.14614
Authors: N. Alam, A. Wright, M. Rutter, I. Buchan, D. Ashcroft, M. Sperrin, A. Renehan |
| 2019 |
Body mass index and Hodgkin\textquoterights lymphoma: UK population-based cohort study of 5.8 million individuals
10.1038/s41416-019-0401-1
Authors: H. Strongman, A. Brown, L. Smeeth, K. Bhaskaran |
| 2021 |
Body mass index and risk of obesity-related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database
10.1002/osp4.474
Authors: C. Haase, K. Eriksen, S. Lopes, A. Satylganova, V. Schnecke, P. McEwan |
| 2023 |
Body mass index and survival in people with heart failure
10.1136/heartjnl-2023-322459
Authors: N. Jones, J. Ordonez-Mena, A. Roalfe, K. Taylor, C. Goyder, F. Hobbs, C. Taylor |
| 2012 |
Body mass index and the incidence of influenza-associated pneumonia in a UK primary care cohort
10.1111/j.1750-2659.2011.00262.x
Authors: W. Blumentals, A. Nevitt, M. Peng, S. Toovey |
| 2018 |
Body mass index and use and costs of primary care services among women aged 55-79 years in England: a cohort and linked data study
10.1038/s41366-018-0288-6
Authors: S. Kent, S. Jebb, A. Gray, J. Green, G. Reeves, V. Beral, B. Mihaylova, B. Cairns |
| 2014 |
Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults
10.1016/s0140-6736(14)60892-8
Authors: K. Bhaskaran, I. Douglas, H. Forbes, I. dos-Santos-Silva, D. Leon, L. Smeeth |
| 2017 |
Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England
10.1371/journal.pone.0173515
Authors: W. Herrington, M. Smith, C. Bankhead, K. Matsushita, S. Stevens, T. Holt, F. Hobbs, J. Coresh, M. Woodward |
| 2015 |
Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis
10.1007/s00223-015-9993-5
Authors: J. Driessen, R. Henry, H. van Onzenoort, A. Lalmohamed, A. Burden, D. Prieto-Alhambra, C. Neef, H. Leufkens, F. de Vries |
| 2014 |
Bone fractures in children with autistic spectrum disorder
10.1097/dbp.0000000000000070
Authors: R. Furlano, M. Bloechliger, H. Jick, C. Meier |
| 2004 |
Breast cancer incidence and use of antihypertensive medication in women
10.1002/pds.910
Authors: A. Gonzalez-Perez, G. Ronquist, L. Rodriguez |
| 2005 |
Breast cancer risk among users of antidepressant medications
Authors: A. Gonzalez-Perez, L. Rodriguez |
| 2014 |
Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project
Authors: V. Abbing-Karahagopian, X. Kurz, F. de Vries, T. van Staa, Y. Alvarez, U. Hesse, J. Hasford, Lv Dijk, F. de Abajo, J. Weil, L. Grimaldi-Bensouda, A. Egberts, R. Reynolds, O. Klungel |
| 2017 |
Bronchiectasis and the risk of cardiovascular disease: a population-based study
10.1136/thoraxjnl-2015-208188
Authors: V. Navaratnam, E. Millett, J. Hurst, S. Thomas, L. Smeeth, R. Hubbard, J. Brown, J. Quint |
